These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 8315378

  • 1. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
    Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG.
    J Exp Med; 1993 Jul 01; 178(1):197-209. PubMed ID: 8315378
    [Abstract] [Full Text] [Related]

  • 2. Protective immunity elicited by rBCG vaccines.
    Stover CK, Bansal GP, Langerman S, Hanson MS.
    Dev Biol Stand; 1994 Jul 01; 82():163-70. PubMed ID: 7958471
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
    Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.
    Vaccine; 1999 Feb 26; 17(7-8):904-14. PubMed ID: 10067697
    [Abstract] [Full Text] [Related]

  • 4. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi.
    Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S.
    Nature; 1994 Dec 08; 372(6506):552-5. PubMed ID: 7990928
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA, De Luca K, Durand PY, Feilmeier B, DeWitt K, Sigoillot-Claude C, Sajous ML, Day MJ, David F.
    BMC Vet Res; 2018 Oct 16; 14(1):312. PubMed ID: 30326885
    [Abstract] [Full Text] [Related]

  • 8. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y.
    Vaccine; 1995 Apr 16; 13(5):435-41. PubMed ID: 7639011
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R, Siebers A, Jahraus O, Brenner C, Stehle T, Simon MM.
    Infect Immun; 2001 Apr 16; 69(4):2130-6. PubMed ID: 11254567
    [Abstract] [Full Text] [Related]

  • 10. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K, Dizij A, Voet P, Hauser P, Simon MM.
    Vaccine; 1997 Oct 16; 15(15):1670-4. PubMed ID: 9364698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A recombinant vaccine for Lyme disease.
    Wallich R, Kramer MD, Simon MM.
    Behring Inst Mitt; 1994 Dec 16; (95):106-8. PubMed ID: 7755503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new approach to a Lyme disease vaccine.
    Livey I, O'Rourke M, Traweger A, Savidis-Dacho H, Crowe BA, Barrett PN, Yang X, Dunn JJ, Luft BJ.
    Clin Infect Dis; 2011 Feb 16; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J.
    Vaccine; 1995 Aug 16; 13(12):1086-94. PubMed ID: 7491816
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.